Botanical species · safety record

Eucalyptus globulus

The EFSA Compendium of Botanicals holds 5 constituent measurements and 1 genotoxicity assay for Eucalyptus globulus. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Eucalyptus globulus Labill.

5Constituent measurements

1Safety records

3Cited sources

729Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 729 licensed products naming Eucalyptus globulus as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Source material stated

Branch terminal leafy
Dried leaf
Dried leaves
Dried leaves of older twigs
Dried secondary leaves of older trees
Essential oil from leaf
Essential oil of Eucalyptus
Eucalyptus

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
(-)-globulol	Leaves	Essential oil	6.95 Percent	GC-MS	Resolve DOI
1,8-cineole	Leaves	Essential oil	78.45 Percent	GC-MS	Resolve DOI
1,8-cineole	Aerial part of plants	Essential oil	81.9 Percent	GC-MS	Resolve DOI
1,8-cineole	Leaves	Essential oil	49.05 Percent	GC-MS	Resolve DOI
Pinocarvone	Leaves	Essential oil	1.34 Percent	GC-MS	Resolve DOI

Genotoxicity testing

Outcomes of genotoxicity assays as recorded in the source. A negative assay is a result under those test conditions, not a clearance.

Outcome	Endpoint	Test	Tested organism	Metabolic activation	Source
Positive	chromosome aberration	chromosome aberration assay	Other	No data	Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Miyamoto, C. T., Rocha de Sant'Anna, J., da Silva Franco, C. C., Cunico, M. M., Miguel, O. G., Cocco, L. C., Yamamoto, C. I., Correa, C., Jr., de Castro-Prado, M. A. A. Genotoxic Activity of Eucalyptus globulus Essential Oil in Aspergillus nidulans Diploid Cells. Folia microbiologica, 2009, vol. 54, no. 6, p. 493-498. DOI
Atmani-Merabet, Ghania., Belkhiri, Abdelmalik., Dems, Mohamed Abdeslam., Lalaouna, Abdeldjallil., Khalfaoui, Zakaria., Mosbah, Bouzid. Chemical composition, toxicity, and acaricidal activity of Eucalyptus globulus essential oil from Algeria. Current issues in pharmacy and medical sciences, 2018, vol. 31, no. 2, p. 89-93. DOI
George, David R., Masic, Dino., Sparagano, Olivier A. E., Guy, Jonathan H. Variation in chemical composition and acaricidal activity against Dermanyssus gallinae of four eucalyptus essential oils. Experimental and applied acarology, 2009, vol. 48, no. 1-2, p. 43-50. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature